feed,title,long_url,short_url
Benzinga,Fulcrum Therapeutics Shares Additional Data From Phase 1 Trial Of Sickle Cell Disease Treatment,https://benzinga.com/general/biotech/21/12/24457956/fulcrum-therapeutics-shares-additional-data-from-phase-1-trial-of-sickle-cell-disease-treatment,https://j.mp/3rEFDg9
Benzinga,"Gritstone bio, CEPI Expand COVID-19 Vaccine Agreement to Combat Omicron Variant",https://benzinga.com/general/biotech/21/12/24457919/gritstone-bio-cepi-expand-covid-19-vaccine-agreement-to-combat-omicron-variant,https://j.mp/3Dsv822
